However, it is well documented that CCN5 may inhibit phosphorylation of AKT in both estrogen-receptor α (ER-α)–negative and ER-α–positive breast cancer cells as well as in certain other cancer cell lines (23, 24, 25, 26). This evidence concerns the gene ESR1 and breast carcinoma.